Revyve Secures €24 Million Funding to Boost Egg-Replacing Yeast Proteins
WAGENINGEN,
The Series B round was co-led by ABN AMRO Sustainable Impact Fund and Invest-NL with regional support from Brabantse Ontwikkelings Maatschappij (BOM) and strategic investments by Lallemand Bio-Ingredients' Swiss affiliate Danstar Ferment and Grey Silo Ventures (CVC of Cereal Docks Group). Existing investors Oost NL and Royal Cosun doubled down on their commitment. This diverse investor base combines institutional, public, and strategic expertise to back Revyve's mission of reshaping and transforming the alternative protein space by powering next-gen clean-label solution.
Clean-label solutions for a changing food landscape
Revyve produces highly functional yeast proteins that mimic the performance of eggs in food categories such as bakery, sauces, alternative meat and plant-based dairy. Unlike many substitutes, Revyve's ingredients are natural, more sustainable, and price competitive, helping manufacturers respond to three pressing industry challenges:
- Rising egg costs: Volatile pricing is driving demand for affordable and price stable alternatives.
- Scrutiny of ultra-processed foods: Brands are under pressure to eliminate additives while keeping functionality.
- Sustainability: Major retailers and food manufacturers are demanding cuts to CO₂ footprints across the supply chain.
"Food manufacturers are cutting back on eggs to offset increasing prices and reach sustainability targets, but replicating their unique functionality is crucial to maintaining the texture and mouthfeel consumers are used to. This is exactly where our Yeast Proteins come in, providing an affordable and clean label solution for egg replacement or egg reduction" said
Scaling production in
In 2024, Revyve commissioned its first-of-a-kind (FOAK) production facility in Dinteloord,
Verstraeten adds: "Strong regional support from both the Wageningen and Brabant ecosystems has enabled us to scale to industrial levels in record time. With a stellar team and strong investor backing, we have an incredibly solid foundation for global expansion."
Strong investor backing
The Series B round marks strong confidence in Revyve's proprietary technology and market potential.
- "We are excited to partner with Revyve as they pioneer pressing sustainable alternatives to traditional egg ingredients. Their solution addresses a critical need in the food transition: scalable ingredients with a low environmental footprint and compelling economics for food manufacturers. We believe this combination of commercial viability and measurable sustainable benefits makes Revyve uniquely positioned to grow into a global leader. We look forward to supporting their journey." said
Hanna Zwietering , ABN AMRO SIF Senior Investment Manager. Lisette Kersting-van der Boog , Senior Investment Manager of Invest-NL adds: "With their functional egg-replacement ingredients, Revyve can play a major role in accelerating the global protein transition and fostering circular solutions that reduce pressure on land, water and animals. We are proud to invest in this Dutch company, which strengthens the country's innovative power with a pioneering technology that has the potential to transform food production worldwide."- Furthermore, the plans of Revyve fit perfectly in the BOM's ambition to grow Brabant into 'the Scale-Up Plant of
Europe ': "Revyve's plans align seamlessly with our mission to position Brabant as the Scale-Up Plant ofEurope . Their breakthrough technology not only contributes to a more sustainable food system but also exemplifies the kind of bold innovation we aim to foster in the region. We're proud to support Revyve in scaling their impact from Brabant to the world," addedIngrid Nieweg , Investment Manager at BOM." - Lallemand Bio-Ingredients and Grey Silo Ventures (CVC of Cereal Docks Group) complete Revyve's Series B round, bringing a wealth of knowledge and synergies in yeast innovation and agri-food expertise.
Looking ahead
With industrial production in full swing, Revyve is already serving customers across
About Revyve
Revyve, is a purpose-driven food-tech company committed to creating a more sustainable food system. The team of scientists and food industry experts at Revyve share a common vision of enhancing the sensory experience of food through incredible texture. The company arose from Wageningen University & Research (WUR) in
www.revyve.bio
About ABN AMRO Sustainable Impact Fund
The ABN AMRO Sustainable Impact Fund is one of the largest private impact funds in
ABN AMRO Sustainable Impact Fund - ABN AMRO
About Invest-NL
Invest-NL is the National Promotional Institution of
About Brabantse Ontwikkelingsmaatschappij (BOM)
The Brabant Development Agency (BOM) works together with entrepreneurs to create a future-proof Brabant economy. We share knowledge, develop networks, and provide capital to innovative Brabant companies and sustainable energy projects. We also encourage forward-looking international companies to settle in Brabant and assist companies already based in Brabant to extend their reach abroad.
About Grey Silo Ventures
Grey Silo Ventures is the Corporate Venture Capital arm of Cereal Docks Group, dedicated to investing in non-animal-based ingredients and breakthrough technologies in food-tech and ag-tech. With deep roots in plant-based processing, Grey Silo Ventures supports innovation in fermentation, green proteins, cellular agriculture, and functional ingredients.
About Lallemand Bio Ingredients
Lallemand Bio-Ingredients is business unit of Lallemand Inc which is a privately-owned business, headquartered in
For press inquiries, please contact:
- Liat Simha, PR expert, @NutriPR | [email protected] | +972-9-974-2893
- Bhakti Rajesh Pawani, Marketing and Business Development Manager @ Revyve | [email protected]
- Marieke Ziedses des Plantes, Senior Press Officer @ ABN AMRO | [email protected]
- Wander
van der Kolk , Head of Marketing Communication @ Invest-NL |[email protected]
Photo - https://mma.prnewswire.com/media/2778025/Revyve_Funding.jpg
View original content to download multimedia:https://www.prnewswire.com/news-releases/revyve-secures-24-million-funding-to-boost-egg-replacing-yeast-proteins-302562351.html
SOURCE Revyve
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Thryv Therapeutics Licenses a New Class of SGK1 Inhibitors from Spain's CSIC and Universidad Autónoma de Madrid, Extending Its Platform into Neurodegenerative Disease
- GraniteShares Files for 2x Long and 2x Short Anthropic ETFs AIL & ANS
- New U.S. Treatment Recommendations Published for Severe Alopecia Areata in Adults
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Industrial ProductionSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share